High/low-dose oral cepharanthine vs placebo in non-hospitalised asymptomatic or mild COVID-19
Asymptomatic COVID-19
Enrolment: 450 · Results not recorded
Loading the evidence…
Drug
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Asymptomatic COVID-19
Enrolment: 450 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Renal ischaemia-reperfusion
Cepharanthine attenuated the rise in BUN and creatinine and reduced kidney tissue damage after renal ischaemia-reperfusion.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.